History | Mavacamten for treating symptomatic obstructive hypertrophic cardiomyopathy | Guidance | NICE

History

Expected publication

Equality Impact Assessment (Guidance development) (PDF 140 KB)

Published:

06 September 2023
Register of interests (PDF 128 KB)

Published:

06 September 2023

Final draft guidance

Final draft guidance
Final draft guidance (PDF 222 KB)

Published:

02 June 2023
Committee papers (PDF 9.21 MB)

Published:

02 June 2023
Public committee slides (PDF 1.67 MB)

Published:

02 June 2023
Final draft guidance Equality Impact Assessment (PDF 140 KB)

Published:

02 June 2023

Invitation to participate

Final stakeholder list (PDF 165 KB)

Published:

04 February 2022
Final scope (PDF 193 KB)

Published:

04 February 2022
Draft scope and provisional stakeholder list comments table (post-referral) (PDF 280 KB)

Published:

04 February 2022
Equality Impact Assessment (Guidance development) (PDF 124 KB)

Published:

04 February 2022

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators

Draft scope post referral (PDF 208 KB)

Published:

02 July 2021
Draft matrix post referral (PDF 168 KB)

Published:

02 July 2021